Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 122, Issue 11, Pages 4231-4242
Publisher
American Society for Clinical Investigation
Online
2012-10-15
DOI
10.1172/jci63917
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TPL-2/COT AND COX-2 IN BREAST CANCER
- (2012) Zuzana Krcova et al. BIOMEDICAL PAPERS-OLOMOUC
- Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation
- (2012) O. B. Serebrennikova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal Cells of the Intestinal Lamina Propria
- (2011) D.W. Powell et al. Annual Review of Physiology
- Tpl2 kinase signal transduction in inflammation and cancer
- (2011) Maria Vougioukalaki et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
- (2011) Bhagelu Ram Achyut et al. GASTROENTEROLOGY
- Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?
- (2011) M Lawrenz et al. Mucosal Immunology
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Microenvironmental regulation of stem cells in intestinal homeostasis and cancer
- (2011) Jan Paul Medema et al. NATURE
- Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
- (2011) A. Bronisz et al. NATURE CELL BIOLOGY
- In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
- (2011) Neelesh Sharma et al. Therapeutic Advances in Medical Oncology
- Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
- (2010) Thorsten Gantke et al. CELL RESEARCH
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion
- (2010) Anisa Shaker et al. JOURNAL OF CLINICAL INVESTIGATION
- An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer: Figure 1.
- (2010) Mark Asquith et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis
- (2010) K L DeCicco-Skinner et al. ONCOGENE
- Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability
- (2010) Magdalena Skrzypczak et al. PLoS One
- Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease
- (2009) D. George et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes
- (2009) Michael Karin et al. IMMUNOLOGICAL REVIEWS
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasms
- (2008) Pierpaolo Trimboli et al. CLINICAL ENDOCRINOLOGY
- Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
- (2008) Maria Armaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras
- (2008) Y. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells
- (2008) C. Tsatsanis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started